Ruthenium complexes containing 2,6-bis(benzimidazolyl)pyridine derivatives induce cancer cell apoptosis by triggering DNA damage-mediated p53 phosphorylation.
about
Cytoxicity and apoptotic mechanism of ruthenium(II) amino acid complexes in sarcoma-180 tumor cellsInfluence of substituents on DNA and protein binding of cyclometalated Ir(iii) complexes and anticancer activity.Strategy to enhance the therapeutic effect of doxorubicin in human hepatocellular carcinoma by selenocystine, a synergistic agent that regulates the ROS-mediated signaling.Two half-sandwiched ruthenium (II) compounds containing 5-fluorouracil derivatives: synthesis and study of DNA intercalation.New benzimidazole acridine derivative induces human colon cancer cell apoptosis in vitro via the ROS-JNK signaling pathway.Green tea polyphenols induce cell death in breast cancer MCF-7 cells through induction of cell cycle arrest and mitochondrial-mediated apoptosis.Metallomics insights into the programmed cell death induced by metal-based anticancer compounds.Transferrin-functionalized nanographene oxide for delivery of platinum complexes to enhance cancer-cell selectivity and apoptosis-inducing efficacy.The potential anti-proliferative effect of β-sitosterol on human mast cell line-1 cells.A selenium-containing ruthenium complex as a cancer radiosensitizer, rational design and the important role of ROS-mediated signalling.Mixed-ligand ruthenium polypyridyl complexes as apoptosis inducers in cancer cells, the cellular translocation and the important role of ROS-mediated signaling.Differential effects of amino acid surface decoration on the anticancer efficacy of selenium nanoparticles.Zinc(II) complexes containing bis-benzimidazole derivatives as a new class of apoptosis inducers that trigger DNA damage-mediated p53 phosphorylation in cancer cells.Highly stable selenadiazole derivatives induce bladder cancer cell apoptosis and inhibit cell migration and invasion through the activation of ROS-mediated signaling pathways.Rational Design of Ruthenium Complexes Containing 2,6-Bis(benzimidazolyl)pyridine Derivatives with Radiosensitization Activity by Enhancing p53 Activation.Selenadiazole derivatives antagonize hyperglycemia-induced drug resistance in breast cancer cells by activation of AMPK pathways.Antiangiogenic ruthenium(ii) benzimidazole complexes, structure-based activation of distinct signaling pathways.Aquation Is a Crucial Activation Step for Anticancer Action of Ruthenium(II) Polypyridyl Complexes to Trigger Cancer Cell Apoptosis.Licochalcone D induces apoptosis and inhibits migration and invasion in human melanoma A375 cells.
P2860
Q28543888-DB11DFB9-943A-45A0-B455-B8C866DAAD70Q32174625-D99A55C9-92FC-4E83-8216-91AE96E32D46Q33757127-C20BAC6B-C4C6-4F1C-A008-F85764B773FEQ35581166-C1156C26-1F1D-4EB2-A509-88C79C003740Q36034242-71777876-2005-4DCB-A79F-D63D7FE18D6DQ37629741-6A0D95F8-4627-42D3-85ED-4E4F124EB324Q38199383-CC8A48A7-F887-414D-B106-C77CEE839551Q38648996-A4C0895E-327C-4E6F-909D-05FDA1B96521Q38840327-14E5800B-2A33-4436-8348-DC8F34A26F1AQ38921651-BC36A650-F87E-4894-B335-3A4C12BB6092Q38969205-BD8CB87F-2BDF-4142-A0FC-A4FB98DCB8BFQ39060581-AC49E273-530E-4E13-927D-12667ECA8097Q39184979-EFF22183-BCFF-4A14-A53F-B3928B7FB4B5Q46480998-3BE1AD3F-435B-47AA-894F-04E7CAAB2EAFQ46737262-37E13733-9911-4B0D-A938-C8EDC5106ADFQ50663693-6066E27B-2B4F-43EE-A92E-76805DDBF492Q51013825-422834CE-2509-42E4-9378-D5A7E7A7244DQ53463488-C212A545-D3AC-4B85-990F-F7415471781FQ54937151-F8B8E5E4-C44D-4EA2-83A1-0E3736D2A817
P2860
Ruthenium complexes containing 2,6-bis(benzimidazolyl)pyridine derivatives induce cancer cell apoptosis by triggering DNA damage-mediated p53 phosphorylation.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Ruthenium complexes containing ...... -mediated p53 phosphorylation.
@en
Ruthenium complexes containing ...... -mediated p53 phosphorylation.
@nl
type
label
Ruthenium complexes containing ...... -mediated p53 phosphorylation.
@en
Ruthenium complexes containing ...... -mediated p53 phosphorylation.
@nl
prefLabel
Ruthenium complexes containing ...... -mediated p53 phosphorylation.
@en
Ruthenium complexes containing ...... -mediated p53 phosphorylation.
@nl
P2093
P2860
P356
P1433
P1476
Ruthenium complexes containing ...... -mediated p53 phosphorylation.
@en
P2093
Cundong Fan
Tianfeng Chen
Wenjie Zheng
Wenqiang Cao
P2860
P304
12766-12772
P356
10.1039/C2DT30665D
P407
P577
2012-11-01T00:00:00Z